TICKERNERD
Menu
POASHealthcare · Medical Devices

POAS Stock Forecast: Phaos Technology Holdings (Cayman) Ltd. Price Predictions for 2026-2027

Last close, 30 Oct 2026
$1.26

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 2 of 100 as at 31 Oct 2026 — in the weakest quartile.

Market cap
$1.5M
Ticker Nerd rank
2/ 100
Median analyst target
—
Analysts covering
—
Ticker Nerd rank

POAS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Phaos Technology Holdings (Cayman) Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 31 Oct 2026
2/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
97
Revisions
25
Accruals
8
Growth
8
Value
5
Issuance
5
Volatility
4
Momentum
3
Quality
3

Size (97): Smaller than most of the companies we track.

Quality (3): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

POAS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on POAS, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

POAS appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Estimates

POAS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Phaos Technology Holdings (Cayman) Ltd. (POAS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
10.5×

Cheaper than 13% of US stocks

Price / book
0.6×

Cheaper than 80% of US stocks

EV / EBITDA
−0.4×

Cheaper than 66% of US stocks

Growth & margins
Revenue growth (YoY)
−57.5%

Higher than 5% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
−10747.8%

Higher than 2% of US stocks

Net margin
13.1%

Higher than 75% of US stocks

Returns & dividend
Return on equity
−369.0%

Higher than 4% of US stocks

Return on assets
−91.8%

Higher than 3% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Phaos Technology Holdings (Cayman) Ltd. (POAS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Phaos Technology Holdings (Cayman) Ltd. has a market value of $1.5M and an enterprise value of $2.1M.

  • Shares outstanding: 16.4M.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Phaos Technology Holdings (Cayman) Ltd. employs 10 people.

market figures as at 31 Oct 2026

Data provided by Twelve Data

Peers

POAS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
POASPhaos Technology Holdings (Cayman) Ltd.$1.5M2
BJDXBluejay Diagnostics, Inc.$2.5M20
AIDX20/20 Biolabs, Inc.$2.8M3
ICCMIceCure Medical Ltd.$3.0M42
NUWENuwellis, Inc.$3.1M15
IVFINVO Fertility, Inc.$2.3M34
ADGMAdagio Medical Holdings, Inc.$2.3M29

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Phaos Technology Holdings (Cayman) Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest POAS news & analysis

Phaos Technology Holdings (Cayman) Limited Provides Required Going Concern Disclosure

GlobeNewsWire · 26 Oct 2026negative

Phaos Technology Holdings said AssentSure PAC’s audit report for the fiscal year ended April 30, 2026 contains a going-concern explanatory paragraph expressing substantial doubt about the company’s ability to continue operating as a going concern.

Why it matters — The disclosure flags substantial doubt about Phaos’s ability to continue operating as a going concern, which is relevant to investors monitoring the company.

Phaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split

GlobeNewsWire · 2 Oct 2026neutral

Phaos Technology Holdings (Cayman) Limited, an advanced microscopy company headquartered in Singapore trading on NYSE American under POAS, announced a one-for-fifteen reverse stock split on October 2, 2026.

Why it matters — A reverse stock split reduces the number of outstanding shares and raises the per-share price, which POAS watchers would care about for potential listing-requirement and share-structure implications.

Phaos Technology Holdings (Cayman) Limited Announces Entry Into Securities Purchase Agreement for an Equity Facility of Up to US$10 Million

GlobeNewsWire · 1 Oct 2026neutral

Phaos Technology Holdings (Cayman) Limited announced it has entered into a securities purchase agreement dated September 28, 2026, with High West Partners LLC, giving the company the right, but not the obligation, to sell up to US$10,000,000 of its Class A ordinary shares at prevailing market prices over a 36-month period. Phaos also agreed to issue Class A ordinary shares to the investor as a commitment fee, fully earned as of the Commencement Date and issued upon delivery of the first purchase notice.

Why it matters — POAS watchers would care because this equity facility gives the company a discretionary source of up to US$10 million in funding through share sales over the next three years, subject to market prices and listing rules.

Phaos Technology Holdings (Cayman) Limited Announces Update on Involvement of Related Parties

GlobeNewsWire · 18 Sept 2026neutral

Phaos Technology Holdings (Cayman) Limited announced an update regarding the involvement of certain related parties of the Company. The announcement was made on September 18, 2026, by the Singapore-based advanced microscopy company.

Why it matters — POAS watchers would follow this because updates on the involvement of related parties can carry governance and disclosure implications for the company.

FAQ

Frequently asked questions about POAS stock

How does Ticker Nerd's model rank POAS?

As at 31 Oct 2026, Phaos Technology Holdings (Cayman) Ltd. ranks 2 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (97 of 100).

What is the POAS stock forecast for 2030?

No analyst covering Phaos Technology Holdings (Cayman) Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for POAS are extrapolating price history, which says nothing about the business.

What does Phaos Technology Holdings (Cayman) Ltd. do?

Phaos Technology Holdings (Cayman) Limited is a Cayman Islands-incorporated investment holding company headquartered in Singapore. Through its subsidiary, the company develops, assembles, and commercializes advanced microscopy-related solutions, technologies, and products for industrial, biomedical, and research applications.

What is the latest news on POAS?

The most recent item we track (GlobeNewsWire, 26 Oct 2026): "Phaos Technology Holdings (Cayman) Limited Provides Required Going Concern Disclosure". Phaos Technology Holdings said AssentSure PAC’s audit report for the fiscal year ended April 30, 2026 contains a going-concern explanatory paragraph expressing substantial doubt about the company’s ability to continue operating as a going concern.

Company

About Phaos Technology Holdings (Cayman) Ltd.

Phaos Technology Holdings (Cayman) Limited is a Cayman Islands-incorporated investment holding company headquartered in Singapore. Through its subsidiary, the company develops, assembles, and commercializes advanced microscopy-related solutions, technologies, and products for industrial, biomedical, and research applications. Its portfolio includes imaging and measurement systems such as Optonano, PT-Industrial, PT-Metrology, PT-Biology, PT-Stereo, and PT-Zoom, alongside proprietary software that supports image analysis, dimensional measurement, inspection, and workflow integration. Phaos Technology serves customers in manufacturing, biomedical services, and research and development, with distribution networks across Singapore, Vietnam, and other parts of Southeast Asia and South Asia. The company focuses on combining optical hardware with software capabilities to deliver microscopy tools used for quality control, material study, failure analysis, and specialized imaging needs.

CEO Mr. Hong Loon Gan · 10 employees · Singapore · https://phaostech.com